internship chemistry R&D okklo life sciences is a biotech start-up company at the Pivot Park in Oss, The Netherlands, working on orphan and neglected diseases. Our platform technology: a targeted approach based on a chemical (cyclodextrin) platform. Our focus: expansion of our R&D collaboration network and projects. For our biCycle chemistry program, a collaboration …
okklo life sciences As a biotech start-up company at the Pivot Park in Oss, The Netherlands, Okklo Life Sciences is building a project portfolio in orphan and neglected diseases. Our platform technology: a targeted approach based on a chemical (cyclodextrin) platform. Apart from our on-going focus to expand our R&D collaboration network and expanding the number …
Together with a number of companies established at the Pivot Park, Okklo Life Sciences will be at the Biomedica Summit in Aachen, Germany on June 18th and 19th, 2013. We are looking forward to making many new contacts with (potential) partners with whom we will be able to advance our projects and business.
On March 28th, okklo life sciences announces a new collaboration – the BiCycle platform ™. In partnership with two other biotech companies, BioConnection and ChemConnection (also located at the Pivot Park), this platform will deliver specialized services for the synthesis and manufacturing of GMP-quality drug products based on cyclodextrins. In addition, the platform will …
Cyclodextrin-based therapies, Okklo’s field of expertise, seem promising in the treatment of some of these orphan diseases. Therefore, we feel highly committed to contribute to the success of the Gordon Research Conference on Lysosomal Disease (with many other partners, including various patient advocacy groups). We do this by offering some financial support, but also by …
okklo life sciences will be participating in the upcoming 12th International Symposium on MPS and related diseases. This meeting will bring together some patients, their parents and families and professionals, providing a platform for sharing of information on all aspects of MPS and related disorders, in order to advance quality of care and treatment. The meeting will be held in …
As of early 2012, okklo life sciences has been located at the newly established Life Sciences Park in Oss, The Netherlands. In June, the address was also registered with the Chamber of Commerce , so that okklo now is an integral part of the rapidly growing community of companies that have been joining the Life …
June 2012 Alex Zwiers participated in CRS Nordic Chapter meeting on Drug Delivery and Targeting in Reykjavik, Iceland, June 3-5, 2012. The meeting was well attended and with a dedicated audience with a keen interest in novel (bio-medical) applications for cyclodextrins, this proved to be an excellent opportunity for okklo life sciences to strengthen relationships …
April 2012 Okklo life sciences was successful in obtaining a grant from Agentschap NL as a member of the IPC funding scheme. In this program, SMEs are required to enter into collaborative projects around selected themes leading to innovations. Okklo was the coordinating member for a group of five SMEs working in/around infectious diseases …
March 2012 Okklo life sciences was invited to attend to 6th B4B meeting organized in Frankfurt from March 9-11, 2012. Brains for Brain (B4B ) is an internationalTask Force on rare genetic diseases involving the brain. The task force is formed by outstanding scientists, clinicians and leaders in the neurological field, working together with biotech …